CareDx Announces Third Quarter 2025 Financial Results
CareDx, Inc. (CDNA)
Last caredx, inc. earnings: 4/30 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.caredxinc.com
Company Research
Source: Business Wire
Total Revenue of $100 Million Increased 21% Year-Over-YearGrew Testing Services Volume to Approximately 50,300, Increase of 13% Year-Over-YearRaised 2025 Revenue Guidance to $372 Million to $376 Million BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) — The Transplant Company — a leading precision medicine company focused on the discovery, development and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today reported financial results for the third quarter ended September 30, 2025.Third Quarter 2025 Financial HighlightsRevenue of $100.1 million, an increase of 21% year-over-yearTesting services revenue of $72.2 million, an increase of 19% year-over-yearTesting services volume of 50,300, an increase of 13% year-over-yearGAAP net income of $1.7 million, compared to a GAAP net loss of $10.6 million in the third quarter of 2024Adjusted EBITDA of $15.3 million, compared to $6.9 million in the third qua
Show less
Read more
Impact Snapshot
Event Time:
CDNA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CDNA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CDNA alerts
High impacting CareDx, Inc. news events
Weekly update
A roundup of the hottest topics
CDNA
News
- CareDx Announces Preliminary Fourth Quarter and Full Year 2025 Financial Results [Yahoo! Finance]Yahoo! Finance
- CareDx Announces Preliminary Fourth Quarter and Full Year 2025 Financial ResultsBusiness Wire
- CareDx and 10x Genomics to Launch ImmuneScape™ Program – A Multiomics Research Platform to Decode Transplant Rejection and Drug Response [Yahoo! Finance]Yahoo! Finance
- CareDx and 10x Genomics to Launch ImmuneScape™ Program – A Multiomics Research Platform to Decode Transplant Rejection and Drug ResponseBusiness Wire
- CareDx (NASDAQ:CDNA) was downgraded by analysts at Craig Hallum from a "buy" rating to a "hold" rating.MarketBeat
CDNA
Earnings
- 11/4/25 - Beat
CDNA
Sec Filings
- 1/15/26 - Form 144
- 1/12/26 - Form 8-K
- 1/7/26 - Form 4
- CDNA's page on the SEC website